Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 126   

Articles published

SHP 3,724.66 +100.48 (2.77%)
price chart
Shire shares rally after drop on surprise CFO departure news as broker comment ...
Shire PLC (LON:SHP) saw its shares rally today following big falls yesterday afternoon on surprise news its chief financial officer is to quit, helped by reassuring broker comment.
Shire plc (SHPG): Can the high growth still justify its August share price?  Simply Wall St
Shire plc – American Depositary (NASDAQ:SHPG) Experiences Heavier than Usual ...  Modern Readers
Shire plc Director and Senior Management Changes
August 21, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) ("Shire" or the "Company"), announces changes to its Executive Committee, as it progresses its strategy to sharpen its focus as a leader in rare diseases.
TOP NEWS: Shire Chief Financial Officer To Leave At End Of 2017  Interactive Investor
Shire CFO Poulton to depart for Boston startup  Financial Times
Shire: At 52-Week Low, Long-Term Opportunity Appears Significant
Shire's* (SHPG) share price recently hit a 52-week low in both its London- and NASDAQ-listed shares. Yet, I continue to struggle to precisely see why this should be the case.
Shire plc (LSE:SHP): Poised For Long-Term Success?
Shire plc (LSE:SHP) is expected to deliver a gigantic earnings per share growth of over 150% over the next year. Presently, with an EPS of $0.78, we can expect an upcoming EPS of around $3.06.
Market Risers: Severn Trent Plc, Shire PLC, Silence Therapeutics plc
Shares of Shire PLC EPIC code: LON:SHP has climbed 1.84% or 66.82 points during the course of today's session so far. Traders are a positive bunch throughout the session.
Shire seeks European marketing approval for dry eye drops
FTSE 100 speciality pharma giant Shire PLC (LON:SHP, NASDAQ:SHPG) said it is making progress in securing marketing approval in Europe for Lifitegrast for dry eye disease.
EXTRA: Shire Submits Marketing Application For Lifitegrast In Europe  Interactive Investor
Shire Gains as it Seeks European Approval For Dry Eye Treatment  TheStreet.com
Shire PLC (SHP): Looking To Captalise On Unmet Needs In Eye Care
Irish biotech giant Shire plc (LON:SHP) received a validation from the UK, in the capacity of the Reference Member State, for its marketing authorization application for lifitegrast.
BHP Billiton plc and Shire plc could be the FTSE 100's best bargains
Around six years ago, FTSE 100 mining stocks were booming -- and BHP Billiton(LSE: BLT) shares reached 2,475p in April 2011. But Chinese demand was slowing, a worldwide oversupply pushed metals and minerals prices down, and we've had a sector ...
Shire plc : Director/PDMR Shareholding
Shire is the leading global biotechnology company focused on serving people with rare diseases. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, ...
Shire Plc (SHPG) Q2 2017 Results - Earnings Call Transcript
For those not able to be the webcast, slides that accompany today's call are located on the Presentations and Webcasts page of shire.com. Our speakers today are Chief Executive Officer, Dr. Flemming Ornskov, and, Jeff Poulton, Shire's Chief Financial ...